Property | Value |
?:abstract
|
-
• Although small with short-term data, our series reports a translational experience of a cardiovascular department facing MACE in COVID-19 patients being acute arterial events the new insight into this COVID-19 pandemic. • COVID-19 infection may trigger a hypercoagulable status leading to challenging MACE and is associated with high mortality rate. • COVID-19 patient with MACE should be treated with both ventilator support, extensive operative cardiac and peripheral revascularization, and the adjunct of heparin which provides better survival chance independently of the infection-related drug treatment.
|
is
?:annotates
of
|
|
?:creator
|
|
?:doi
|
-
10.1016/j.thromres.2020.10.038
|
?:doi
|
|
?:journal
|
|
?:license
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/733849e0cb36dbc2e5509ceaf745623464d5f818.json
|
?:pmcid
|
|
?:pmid
|
|
?:pmid
|
|
?:publication_isRelatedTo_Disease
|
|
?:sha_id
|
|
?:source
|
|
?:title
|
-
Major cardiovascular events in patients with Coronavirus Disease 2019: experience of a cardiovascular Department of Northern Italy
|
?:type
|
|
?:year
|
|